Detection of Aspergillus fumigatus mycotoxins: Immunogen synthesis and immunoassay development

Journal of Microbiological Methods

Volumn 56, Issue 2, 2004, Pages 221-230

  Fox, M ^a   Gray, G ^a   Kavanagh, K ^a   Lewis, C ^a   Doyle, S ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

ELISA; Gliotoxin; Hapten; Immunocompromised; MALDI TOF

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; GLIOTOXIN; ISOCYANIC ACID DERIVATIVE; MYCOTOXIN; THYROGLOBULIN;

ANTIGEN BINDING; ARTICLE; ASPERGILLUS FUMIGATUS; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; ENZYME IMMUNOASSAY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; MYCOSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; BOVINAE; FUNGI; ORYCTOLAGUS CUNICULUS;

EID: 1642441677     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2003.10.009     Document Type: Article

References (26)

1. Amitani R., Murayama T., Nawada R., Lee W.J., Niimi A., Suzuki K., Tanaka E., Kuze F. Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. Eur. Respir. J. 8:1995;1681.
2. Amitani R., Taylor G., Eleziz E., Jones C.L., Mitchell J., Kuze F., Cole P.J., Wilson R. Purification and characterisation of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect. Immun. 63:1995;3266.
3. Annunziato M.E., Patel U.S., Ranade M., Palumbo P.S. p-Maleimidophenyl isocyanate: a novel heterobifunctional linker for hydroxyl to thiol coupling. Bioconjug. Chem. 4(3):1993;212.
4. Belkacemi L., Barton R.C., Hopwood V., Evans E.G. Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection. Med. Mycol. 37(4):1999;227.
5. Chan E.C., Ho P.C. Preparation and characterization of immunogens for antibody production against metanephrine and normetanephrine. J. Immunol. Methods. 266(1-2):2002;143.
6. Daly P., Kavanagh K. Pulmonary Aspergillosis: clinical presentation, diagnosis and therapy. Br. J. Biomed. Sci. 58:2001;197.
7. Daly P., Kavanagh K. Immobilisation of Aspergillus fumigatus colonies in a soft agar matrix allows visualisation of A549 cell detachment and death. Med. Mycol. 40:2002;27.
8. Davies C. Wild D. The Immunoassay Handbook. 1994;8-38 Stockton Press, NY, USA.
9. Denning D.W. Aspergillosis: diagnosis and treatment. Int. J. Antimicrob. Agents. 6:1996;161.
10. Denning D.W. Invasive aspergillosis. Clin. Infect. Dis. 26:1998;781.
11. Duncan R.J., Weston P.D., Wrigglesworth R. A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132(1):1983;68.
12. Ennis O., Corcoran A., Kavanagh K., Mahon B.P., Doyle S. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection. J. Clin. Virol. 22:2001;55.
13. Fraser R.S. Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol. Annu. 28:1993;231.
14. Hermanson G.T. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA.
15. Keough T., Lacey M.P., Trakshel G.M., Asquith T.N. The use of MALDI mass spectrometry to characterise synthetic protein conjugates. Int. J. Mass Spectrom. Ion Process. 169/170:1997;201.
16. Meunier F. Current clinical issues on mycoses in neutropenic patients. Int. J. Antimicrob. Agents. 6:1996;135.
17. Mitchell C.G., Slight J., Donaldson K. Diffusible component from the spore surface of the fungus Aspergillus fumigatus which inhibits the macrophage oxidative burst is distinct from gliotoxin and other hyphal toxins. Thorax. 52(9):1997;796.
18. Richardson M.D., Kokki M.H. Diagnosis and prevention of fungal infection in the immunocompromized patient. Blood Rev. 12:1998;241.
19. Rinaldi M.G. Invasive aspergillosis. Rev. Infect. Dis. 5:1983;1061.
20. Taylor G.W., Donnelly L.E., Murray S., Rendell N.B. Excursions in biomedical mass spectrometry. Br. J. Clin. Pharmacol. 42(1):1996;119.
21. Tuomola M., Harpio R., Mikola H., Knuuttila P., Lindstrom M., Mukkala V.M., Matikainen M.T., Lovgren T. Production and characterisation of monoclonal antibodies against a very small hapten, 3-methylindole. J. Immunol. Methods. 240(1-2):2000;111.
22. Weig M., Frosch M., Tintelnot K., Haas A., Linsmeier B., Heeseman J. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J. Clin. Microbiol. 39(5):2001;1721.
23. Weig M., Gross U., Domhof S., Brunner E. Use of recombinant mitogillin for serodiagnosis of Aspergillus fumigatus-associated diseases. J. Clin. Microbiol. 39(12):2001;4598.
24. Woo P.C., Leung A.S., Lau S.K., Chong K.T., Yuen K.Y. Use of recombinant mitogillin for serodiagnosis of Aspergillus fumigatus-associated diseases. J. Clin. Microbiol. 39(12):2001;4598.
25. Woo P.C., Chan C.M., Leung A.S., Lau S.K., Che X.Y., Wong S.S., Cao L., Yuen K.Y. Detection of cell wall galactomannoprotein Afmp1p in culture supernatants of Aspergillus fumigatus and in sera of aspergillosis patients. J. Clin. Microbiol. 40(11):2002;4382.
26. Yeo S.F., Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev. 15:2002;465.